| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Revenue | $1.31B | +9.5% |
| Cost of Revenue | $400.3M | -5.3% |
| Gross Profit | $913.1M | +17.5% |
| R&D Expense | $262.5M | +9.6% |
| SG&A Expense | $119.9M | -9.3% |
| Operating Income | $322.5M | +98.6% |
| Pre-tax Income | $277.4M | +139.1% |
| Income Tax | $62.2M | +221.9% |
| Net Income | $215.2M | +122.5% |
| EPS (Basic) | $2.50 | +125.2% |
| EPS (Diluted) | $2.46 | +125.7% |
| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $318.9M | +7.8% |
| Accounts Receivable | $123.7M | +4.8% |
| Current Assets | $512.3M | +7.2% |
| Total Assets | $3.38B | -2.0% |
| Current Liabilities | $156.8M | +0.3% |
| Long-term Debt | $957.4M | -9.4% |
| Total Liabilities | $1.27B | -4.5% |
| Stockholders' Equity |
| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $457.1M | +34.5% |
| Capital Expenditures | $2.0M | -5.5% |
| Investing Cash Flow | -$47.1M | +90.7% |
| Financing Cash Flow | -$387.0M | -772.2% |
| Free Cash Flow | $455.1M | +34.7% |
| $2.11B |
| -0.4% |